T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Clinical trials for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests the safety of combining two drugs, ruxolitinib and duvelisib, in people with T- or NK-cell lymphomas that have come back or not responded to prior treatments. About 70 participants will receive the drugs to find the best dose and see if the combinatio…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New hope for rare blood cancer: drug trial targets tumor growth
Disease control Recruiting nowThis study tests a pill called ruxolitinib in 30 adults with a rare type of leukemia (T-LGLL). The drug works by blocking enzymes that help cancer cells grow. The main goal is to see if the drug can shrink tumors and improve quality of life, while monitoring side effects.
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC